Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLAM.L Regulatory News (LAM)

  • There is currently no data for LAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Lamprell plc

7 Jul 2022 16:05

RNS Number : 7463R
Lamprell plc
07 July 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Lamprell plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Lamprell plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 July 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in Lamprell shares held by the directors of Lamprell plc and their close persons and related trusts:

 

Lamprell Director

Role

Number of ordinary shares

Percentage of total issued share capital (3 decimal places)

Christopher McDonald

Chief Executive Officer

942,085

0.156%

Antony Wright

Chief Financial Officer

179,641

0.044%

Mel Fitzgerald

Non-Executive Director

111,700

0.027%

John Malcolm

Non-Executive Chairman

100,000

0.024%

Debra Valentine

Senior Independent Director

75,000

0.018%

 

(b) Retention Share Plan awards

 

Lamprell Director

Role

Date of grant

Exercise price

Number of ordinary shares over which rights have been granted and are outstanding

Date Of vesting

Christopher McDonald

Chief Executive Officer

29 November 2021

Nil

995,199

28 November 2024

Antony Wright

Chief Financial Officer

29 November 2021

Nil

466,322

28 November 2024

 

(c) Performance Share Plan awards

 

Lamprell Director

Role

Date of grant

Exercise price

Number of ordinary shares over which rights have been granted and are outstanding

Date Of vesting

Christopher McDonald

Chief Executive Officer

29 November 2021

Nil

1,990,398

28 November 2024

5 April 2019

Nil

1,402,399

4 April 2022*

Antony Wright

Chief Financial Officer

29 November 2021

Nil

932,644

28 November 2024

5 April 2019

Nil

657,124

4 April 2022*

 

*Note: Performance conditions to be tested and awards to be satisfied based on same.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

7 July 2022

Contact name:

Alexander Ridout, General Counsel and Company Secretary

Telephone number:

+971 4 803 9326

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEASXXEELAEFA
Date   Source Headline
19th Dec 20191:00 pmRNSHolding(s) in Company
9th Dec 20191:02 pmRNSDebt Facility Extension
12th Nov 20199:07 amRNSINJAZAT AND LAMPRELL COLLABORATE TO DIGITISE
22nd Oct 20197:00 amRNSInvestor and analyst site visit
3rd Oct 20197:00 amRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNS2019 Interim Results
2nd Aug 20197:00 amRNSTrading Update
21st May 20198:03 amRNSResult of AGM 2019
18th Apr 20197:00 amRNSNotice of AGM and Annual Report publication
5th Apr 20197:53 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNS2018 Full Year Results
8th Mar 20192:13 pmRNSDirector/PDMR Shareholding
17th Jan 20197:00 amRNSPre-close Trading Statement
27th Dec 20188:12 amRNSNew Contract Award
20th Dec 20182:30 pmRNSNew Contract Award
28th Nov 201812:46 pmRNSHolding(s) in Company
28th Nov 20187:00 amRNSHolding(s) in Company
26th Nov 20187:35 amRNSAscension to Saudi Aramco's Offshore LTA Programme
3rd Oct 20189:44 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20187:00 amRNS2018 Interim Results
18th Jul 20187:00 amRNSTrading Update
18th Jun 20188:00 amRNSUpdate on Saudi strategy
14th Jun 20187:00 amRNSHolding(s) in Company
23rd May 20188:15 amRNSResults of 2018 AGM
23rd May 20187:00 amRNSDirectorate Change
30th Apr 20187:00 amRNSCompletion of Haven rig upgrade project
23rd Apr 20187:00 amRNSNotice of AGM/Annual Report and Accounts
11th Apr 20187:00 amRNSDirector/PDMR Shareholding
10th Apr 20187:00 amRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNS2017 Financial Results
16th Mar 20187:00 amRNSUpdate on joint venture in Saudi Arabia
6th Feb 20187:00 amRNSHolding(s) in Company
24th Jan 20184:40 pmRNSSecond Price Monitoring Extn
24th Jan 20184:35 pmRNSPrice Monitoring Extension
24th Jan 20184:15 pmRNSPre-close Trading Statement
28th Dec 20177:00 amRNSDirectorate Change
30th Nov 20177:00 amRNSProject Update
21st Nov 20177:00 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
30th Oct 20177:00 amRNSDirectorate Change
10th Oct 201712:40 pmRNSDirector/PDMR Shareholding
3rd Oct 20179:15 amRNSDirector/PDMR Shareholding
2nd Oct 201711:22 amRNSDirector/PDMR Shareholding
22nd Sep 20177:00 amRNS2017 Interim Results
11th Sep 20177:00 amRNSAppointment of new Chairman
15th Aug 20177:00 amRNSSettlement with Cameron
12th Jul 20171:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.